Dati Progetto
Num. Contratto
323216
Coordinatore
HELMHOLTZ-ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH (Germania)
Responsabile ENEA
MANCUSO MARIA TERESA - SSPT-BIOTEC (CASACCIA)
Sito WEB
http://www.helmholtz-muenchen.de/…/darkrisk/…/index….
Descrizione
The epidemiological study of Tinea capitis (ringworm) patients has proven useful for the study of carcinogenic effects of low dose radiation. In Dark.risk we will develop a new epidemiological cohort based upon the 24 000 cases irradiated in childhood that we will document to create the Serbian Registry of Tinaea Capitis Children (SRTCC). Unlike many other epidemiological cohorts SRTCC can be used to collect biological materials for molecular epidemiological studies. Dark.risk will prepare the way to use SRTCC biomaterials to quantify the contribution of individual differences in sensitivity to risk from low doses of ionizing radiation. We will focus on a novel and unique process to identify individual differences. Until recently 95% of the human genome was considered to be non-translated “junk" DNA. However, almost all of this “dark matter” is actively transcribed into a vareity of non-coding RNA species (ncRNAs) that regulate interactions with the external environment, such as repressing retrotransposons, regulating gene transcription responses to stress, governing chromatic remodeling and coordinating the translation of mRNAs. The ncRNAs play an essential role in coordinating critical cellular responses to radiation such as maintenance of genomic stability, senescence, apoptosis and survival. As ncRNAs make major contributions to individual disease sensitivity we will investigate precisly how the “dark matter” regulates responses at low doses (1mGy to 500mGy), and how these responses vary between individuals. Our long-term goal is to use ncRNAs as biological markers of exposure and outcome on an individual basis.
Attività svolta da ENEA
L'ENEA si occuperà di individuare sul modello murino, altamente suscettibile agli effetti delle radiazioni ionizzanti, marcatori biomolecolari mediante tecnologia basata sull'uso di mRNA. I risultati ottenuti verranno poi utilizzati nella coorte epidemiologica.
Programma Quadro
Settimo Programma Quadro Euratom (2007-2013)
Programma UE
Euratom fissione
Tipo Progetto
CP - Progetto di collaborazione
Riferimenti ENEA
Posizione:
1235
Atto di Approvazione ENEA:
457/2012/COMM
Codice Atto:
07O14
Unità alla stipula:
UTBIORAD-RAB
Dati Finanziari (in euro)
Costo eleggibile del progetto:
2.265.959,00
Costo eleggibile per ENEA:
412.428,00
Contributo al progetto:
1.735.335,00
Contributo a ENEA:
309.318,00
Durata
Anno di stipula:
2012
Durata (in mesi):
42
Data di inizio:
01-10-2012
Data di scadenza:
31-03-2016
Partner (5)
Ruolo |
Tipologia |
Nome |
Nazione |
COORD |
Istituti di ricerca |
HELMHOLTZ-ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH |
Germania |
PARTNER |
Istituti di ricerca |
ENEA |
Italia |
|
Altro |
ZENSKA ASOCIJACIJA "ROSA" |
Serbia |
|
Altro |
SERVIZO GALEGO DE SAUDE |
Spagna |
|
Università |
UNIV. AUTONOMA BARCELONA |
Spagna |
Keyword associate al progetto dal database di CORDIS (3)
Keyword |
Medical Research |
Radiation And Radioisotope Effects On Man, Animals, Plants And Microorganisms |
SCIENTIFIC RESEARCH |
Altre Keyword non presenti nel database di CORDIS (1)